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Abstract Objective To evaluate whether the presence of maternal blood pressure reduces the
risks of morbidity, perinatal mortality and morbidity at 24 months of age in very low
birth weight infants (VLBWIs) compared with a control group.
Methods A retrospective, observational, case-control study. Total 49 VLBWIs were
allocated to the study group, called the maternal arterial hypertension group (AHG),
and matched with 44 in the control group (CG). The infants were assessed during
hospitalization and at 12 and 24 months corrected age at a specialized clinic. For the
assessment of growth, the World Health Organization (WHO) Anthro software
(Geneva, 2006) was used, and for the psychomotor assessment, the Denver II test
was used.
Results In relation to the antenatal variables, the infants of the AHG had more
centralized circulation assessed by Doppler, received more corticosteroids and mag-
nesium sulfate, and were born by cesarean section more frequently. In terms of the
postnatal and in-hospital outcomes, the AHG had a higher gestational age at birth (30.7
versus 29.6 weeks) and a lower frequency of 5-minute Apgar scores of less than 7
(26.5% versus 52.3%). The CG had a higher rate of pulmonary dysplasia (30.2% versus
8.3%). There were no differences in terms of hospital mortality, complications, somatic
growth and functional problems at 24 months of corrected age.
Conclusion The presence of maternal hypertension, especially preeclampsia, was not
a protective factor against morbidity, mortality and evolution in VLBWIs aged up to 24
months. Therefore, the clinical practice should be focused on prolonging the pregnan-
cy for as long as possible in these conditions as well.
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Introduction
Despite the advances in perinatal medicine, premature birth
is still a serious health problem worldwide, and is the cause
of significant levels of neonatal deaths and permanent
limitations throughout the lives of the individuals affected.1
According to the information available in the Computer
Science Department of The Brazilian Unified Health Care
System (DATASUS, in the Portuguese acronym),2 in the year
2013, there were 331,871 births in Brazil with a gestational
age of between 22 and 36 weeks, corresponding to 11.4% of
the total population of live births. In this same period, the
births of 35,385 children weighing between 500 and 1499 g,
defined as very low weight, were recorded.
In a hospital-based study conducted by a Brazilian
research network, a rate of 12.3% of prematurity was identi-
fied in leadingmaternity units. The main causal factors were
spontaneous premature labor in 36.0%, premature rupture of
the membranes in 29.0%, and elective early labor in 35.0%. In
the latter group, hypertensive syndromes during pregnancy
were the main reasons for the induced labor.3
The population of newborns with birth weights below
1500 g, defined as very low birth weight infants (VLBWIs),
represents a special class among premature births, as it is a
groupconsistingof individualswithahigher individual risk for
neonatal death and for the onset of definitive impairments of
the neuromotor and cognitive skills, including cerebral palsy,
learning difficulties, chronic lung disease and auditory and
visual disorders.4 As the possibilities of survival increase, so
does the amount of follow-up these children require, placing a
greater burden on the health care system.5
A population study conducted in Denmark found that
among individuals born between 1974 and 1996, those born
prematurely, or who suffered fetal growth restriction, pre-
sented a higher risk of hospitalization during adulthood, and
this was linked to a catalog of diseases, including cardiovas-
cular, endocrinal, neurological, obstetric, psychiatric, pul-
monary and urological disorders.6
Identifying the cause of premature labor is of paramount
importance, not only for short-term decision-making, but also
for adopting interventions that can reduce the risk of future
recurrence. The presence of arterial hypertension (AH) during
pregnancy, particularly preeclampsia, represents a serious
threat tomaternaland fetal health, due to thematernal organic
impairment and placental disorders it can cause.
It is calculated thateachyear, thereare~76,000maternal and
500,000 perinatal deaths linked to preeclampsia worldwide.7
Thephysiopathologicalprocesscharacterizedby intense inflam-
mation and endothelial dysfunction results in multiple organ
failure, including placental changes that severely limit fetal
development, and can lead to the death of both the mother
and the child, if labor is not induced.8 Therefore, induced or
elective labor represents, in the majority of cases, the only
alternative for safeguarding the interests of the mother and
child.
In cases related to maternal AH, we see, in Brazil, that
severe maternal morbidity is linked to the delayed adoption
of effective interventions, including the timely interruption
Resumo Objetivo Avaliar se a presença de hipertensão arterial materna reduz os riscos de
morbidade, mortalidade perinatal e morbidade aos 24 meses de idade em recém-
nascidos de muito baixo peso (RNMBPs) em relação a um grupo controle.
Métodos Estudo retrospectivo, observacional, caso controle. Foram alocados 49
RNMBPs no grupo de estudo, chamado de grupo com hipertensão arterial materna
(GHA), e 44 no grupo controle (GC), avaliados durante a internação hospitalar e aos 12
e 24 meses de idade corrigida em ambulatório especializado. Para avaliação do
crescimento, foi adotado o programa WHO Anthro, e o teste de desenvolvimento
de Denver II para a avaliação psicomotora.
Resultados Em relação às variáveis antenatais, fetos do GHA apresentaram mais
centralização da circulação avaliada pelo Doppler, receberam mais corticosteroides e
sulfato de magnésio, além de terem nascido mais por cesáreas. Quanto aos desfechos
pós-natais e durante a internação, o GHA teve idade gestacional de nascimento maior
(30,7  29,6 semanas) e menor frequência de boletim de Apgar no quinto minuto
inferior a 7 (26,5% x 52,3%). Entre as complicações avaliadas, o GC teve maior
frequência de displasia pulmonar (30,2  8,3%). Não houve diferenças em relação à
mortalidade hospitalar, ao crescimento somático e às complicações funcionais aos 24
meses de idade corrigida.
Conclusão A presença de hipertensão arterial materna, em especial a pré-eclâmpsia,
não foi fator de proteção quanto à morbidade, mortalidade e evolução até os 24 meses
de idade em RNMBPs. Desta forma, a prática clínica deve ser voltada para garantir o
maior prolongamento possível da gestação também nestas condições.
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► nascimento prematuro
► desenvolvimento
infantil
► pré-eclâmpsia
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of the pregnancy.9 Based on a study that evaluates this issue,
it can be inferred that this level of care has a direct impact on
the conditions of birth, and increases the future risks.
It appears that there is no information available to identify
whether, among the causal facts linked to the occurrence of
premature labor, there are any specific conditions with a
differentiated prognosis for immediate and later complica-
tions. This is a complex issue, due to the intricate web of
variables that can affect the final outcomes.
We therefore believe that evaluating the early and late
prognosis of VLBWIs due to elective prematurity associated
with maternal AH, and comparing these outcomes with
VLBWIs due to other maternal conditions, can contribute
to this issue, offering some support for clinical decision-
making in this area.
Methods
A retrospective, observational and analytical case control
studywas conducted at a hospital in the city of São Paulo that
is part of the Brazilian Unified Health Care System (SUS, in
the Portuguese acronym), linked to the Escola Paulista de
Medicina [São Paulo School of Medicine]. The eligible popu-
lation consisted of 125 VLBWIs born between January 2004
and December 2007. Out of this number, 93 VLBWIs met the
inclusion criteria; 49 were allocated to the maternal AH
group (AHG) and 44 to the control group (CG).
After discharge from thehospital, the infantswere sent for
follow-up at the outpatient department for premature
babies, with the supervision of the Neonatal Pediatrics
Department of the Escola Paulista de Medicina. The data
were analyzed through a follow-up visit at between 12 and
24 months of corrected age; 28 children of the AHG com-
pleted this phase, and 21 of the CG did the same.
The exclusion criteria for both groups were the presence
of at least one of these conditions, such as premature rupture
of the membranes with clinical or laboratory signs of
maternal or fetal infection, diabetes mellitus, premature
dislocation of the placenta, placenta previa, multiple preg-
nancy and congenital malformation.
The maternal and fetal antenatal epidemiological data
were analyzed, including maternal age, type of hypertensive
syndrome, the cause of premature labor in the CG, fetal
presentation, the type of labor, the use of antenatal corti-
costeroids (ACs) to accelerate fetal maturity, and the use of
magnesium sulfate.
After birth, the outcomes related to the labor and the
hospitalization period were analyzed, including birth
weight, the 5-minute Apgar score, adequacy of weight for
gestational age, gestational age, need for resuscitation in the
labor room, respiratory discomfort syndrome, mechanical
ventilation time, retinopathy of prematurity, ventricular
hemorrhage, ventricular leukomalacia, necrotizing entero-
colitis, sepsis, meningitis, bronchopulmonary dysplasia,
hospitalization time, and in-hospital mortality.
The anthropometric data taken in the outpatient depart-
ment included weight, length, and head circumference, taken
at between 12 and 24 months of corrected age, calculated
using the World Health Organization WHO Anthro software
(Geneva, 2006), version 1.0.4 (available at: who-anthoplus.
sharewarejunction.com), takingasreference thegrowthcurves
developed by the WHO (2006).10 The Z Score (ZS) categories
were adopted, defined as: ZS < -2 ¼ low for age; -2 
ZS  þ2 ¼ adequate for age; and þ2  ZS ¼ high for age.
At 24 months of corrected age, the presence of neurolo-
gical limitations was analyzed (muscle tone, convulsions), as
well as auditory deficiencies (failure in the evoked otoacous-
tic emissions or brain stem auditory evoked potential tests)
and limitations in psychomotor development, determined by
the Denver II Developmental Screening Test.11
For the data analysis, Student’s t-test was used for the
averages, or the Mann-Whitney test for the comparisons
between medians. For the categorical variables, the Chi-
squared test or Fisher’s exact test was used. In all of the
analyses, a level of significance of p < 0.05 was used. The
project was analyzed and approved by the Research Ethics
Committee of the Universidade Federal de São Paulo, regis-
tered under opinion # 1799/2007.
Results
In the AHG, preeclampsia was present in 87.8% of the cases,
whether in isolation or associatedwith chronic AH. In the CG,
the main causes of the low birth weight were premature
rupture of the membranes and spontaneous premature
labor, both with a rate of 34.1%. The remaining causes
were related to diverse conditions, such as acute fetal risk
and cervical incompetence (►Table 1).
In terms of the conditions that precede labor, there were
similarities in both groups in relation to maternal age and
type of fetal presentation, but among the fetuses of the AHG,
the presence of circulatory adaptation in response to pla-
cental insufficiency (fetal centralization) was statistically
significant, as was the administration of ACs andmagnesium
Table 1 Etiological factors related to prematurity in very low
birth weight infants (VLBWIs) in the arterial hypertension group
(AHG; n ¼ 49) and in the control group (CG; n ¼ 44)
Etiological factor N %
Arterial hypertension group
Preeclampsia 33 67.3
Preeclampsia with CAH 10 20.5
Essential arterial hypertension 06 12.2
Total 49 100.0
Control group
Premature rupture of the membranes 15 34.1
Spontaneous premature labor 15 34.1
Fetal risk 11 25.0
Maternal risk 03 6.8
Total 44 100.0
Abbreviation: CAH, chronic arterial hypertension.
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sulfate. Cesarean sections were also more frequent in this
group. In both groups, there were high rates of cesarean
section: 95.9% in the AHG, and 59.1% in the CG (►Table 2).
In relation to the neonatal in-hospital outcomes,►Table 3
shows that both groups were similar in terms of birth weight
and number of infants small for gestational age, the need for
resuscitation in the labor room, the number of days of
hospitalization, and the amount of time on assisted ventila-
tion. However, the AHG showed significant differences in
relation to gestational birth age (30.7 versus 29.6 weeks) and
5-minute Apgar score below 7 (26.5 versus 52.3%).
►Table 3 also shows that the long period of hospitaliza-
tion required the care of a significant number of neonatal
complications, which were evenly distributed in both
groups, with emphasis on the high rates of retinopathy of
prematurity, ventricular hemorrhage and sepsis. Of the
complications evaluated, a significant difference was
detected: pulmonary dysplasia was less frequent in the
AHG than in the CG (8.3 versus 30.2%).
In relation to in-hospital mortality, the rate of deaths in
the general population was of 20.4%; the comparison be-
tween the groups did not showany significant differences; in
the CG, the absolute number of deathswas practically double
that of the AHG. The mortality rates also followed a similar
Table 2 Maternal and antenatal variables in very low birth
weight infants (VLBWIs) in the arterial hypertension group
(AHG; n ¼ 49) and in the control group (CG; n ¼ 44)
Variable AHG CG p
n % n %
Maternal agea 28.8  6.1 27.1  7.3 0.240
Fetal presentation
Cephalic 28 60.9 31 70.4 0.651
Breech 13 28.2 09 20.5
Shoulder 05 10.9 04 9.0
Centralization
on Doppler
28 57.1 09 20.9 < 0.001
Antenatal
corticosteroids
45 91.8 32 72.7 0.015
Magnesium sulfate 27 55.1 – – < 0.001
Type of labor
Vaginal 02 4.1 18 40.9
Cesarean section 47 95.9 26 59.1 < 0.001
aNote: Mean standard deviation, significant p values.
Table 3 Neonatal outcomes of very low birth weight infants (VLBWIs) in the arterial hypertension group (AHG; n ¼ 49) and in the
control group (CG; n ¼ 44)
Variable AHG CG p
n % n %
Birth weight (grams)a 1,118.6  275.4 1,096.6  278.4 0.703
Gestational agea 30.7  2.5 29.6  2.6 0.044
Days of hospitalizationb 42.0 (1 – 96) 47.5 (1–174) 0.262
Days on ventilationb 09.0 (1–63) 11.5 (1 -174) 0.237
Apgar score < 7 13 26.5 23 52.3 0.011
Small for GA 23 46.9 13 29.5 0.086
Resuscitation in labor 8 16.3 14 31.8 0.108
Respiratory discomfort 39 79.6 37 86.0 0.415
Retinopathy 34 82.9 26 74.3 0.357
Ventricular hemorrhage 24 51.1 15 36.6 0.173
Cerebral leukomalacia 3 6.4 2 4.7 0.099
Necrotizing enterocolitis 4 8.3 1 2.3 0.365
Sepsis 17 35.4 18 41.9 0.528
Meningitis 2 4.2 3 7.0 0.664
Pulmonary dysplasia 4 8.3 13 30.2 0.007
Total hospital deaths 7 14.3 12 27.3 0.121
Deaths by weight category
< 750 g 5/7 71.4 4/5 80.0 > 0.999
750 – 1,000 g 1/6 16.7 4/12 33.3 0.615
1,001 – 1,250 g 1/18 5.6 1/10 10.0 > 0.99
1,251 – 1,499 g 0/18 – 3/17 17.6 0.104
Abbreviation: GA, gestational age, aNote: Mean standard deviation; bmedian, maximum and minimum; statistically significant.
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patternwhen analyzed by birthweight categories. Newborns
weighing less than 750 g had markedly reduced chances of
survival in both groups (61.4% versus 80.0%), and the risk of
death was significantly reduced for infants weighing at least
1,000 g (►Table 3).
In relation to the outpatient evaluation, the loss to follow-
up of 14 infants in the AHG and 11 in the CG is noted. In
relation to the ZSs relative to somatic growth, the compar-
ison between the groups did not identify any significant
differences in relation to weight, length or head circumfer-
ence for the age at the evaluation (►Table 4).
In terms of functional deficiencies, both groups showed
similar rates of neurological, auditory and motor problems
(►Table 5).
Discussion
Premature labor is the highest cause of neonatal morbidity
and mortality worldwide. Various risk factors are associated
with its occurrence. It is spontaneous in around 75.0% of
cases, whether associated or not with the premature rupture
of the membranes. The remaining cases are due to elective
indications, mainly because of problems such as preeclamp-
sia and placental insufficiency.12
Based on the results of a Brazilian multicenter trial3 to
evaluate the causes of premature labor in Brazil, using
hospital information, we can consider that, in our country,
35.0% of premature births are the result of the elective
interruption of the pregnancy, mainly due to complications
associated with hypertensive states. In this same study, it
was found that 21.0% of the births occurred at less than
32 weeks, an age range that includes very low birth weight
infants (less than 1,500 g). Our results, although originating
in a single center, are similar to those of the aforementioned
study, in terms of causal factors, but it is not possible to
affirmwhether the outcomes seen in this specific population
can be extrapolated on a wider scale.
Newborns in this weight category are part of a group that,
from the very first moments of birth, depends on numerous
Table 4 Z scores (ZS) calculated between 12 and 24 months of
age in very low birth weight infants (VLBWIs), in the arterial
hypertension group (AHG; n ¼ 49) and in the control group
(CG; n ¼ 44)
Variable AHG CG p
n % n %
Weight for age (W/A) 0.639
ZS W/A < -2 2 7.1 3 14.3
-2  ZS W/A  þ2 26 92.6 18 85.7
Length for age (L/A) 0.443
ZS L/A < -2 3 10.7 4 19.1
-2  ZS L/A  þ2 25 89.3 17 80.9
Head circumference for age (HC/A) 0.789
ZS HC/A < -2 – – 1 5.0
-2  ZS HC/A  þ2 25 89.3 17 85.0
ZS HC/A > þ2 3 10.7 2 10.0
Note: 20 controls evaluated.
Table 5 Functional abnormalities at 24 months of life in very low birth weight infants (VLBWIs), according to birth weight
categories, in the arterial hypertension group (AHG; n ¼ 28) and in the control group (CG; n ¼ 21)
Abnormality AHG CG p
yes no total yes no total
n % n % n % n % n % n %
Neurological
751 – 1,000 g – – 4 100.0 4 100.0 – – 7 100.0 7 100.0
1,001 – 1,250 g 2 20.0 8 80.0 10 100.0 2 33.3 4 66.7 6 100.0 0.604
1,251 – 1,499 g 1 7.1 13 92.9 14 100.0 2 25.0 6 75.0 8 100.0 0527
Total 3 10.7 25 89.3 28 100.0 4 19.0 17 81.0 21 100.0 0.443
Auditory
751 – 1,000 g – – 4 100.0 4 100.0 – – 7 100.0 7 100.0
1,001 – 1,250 g 2 20.0 8 80.0 10 100.0 1 16.6 5 83.3 6 100.0 1.000
1,251 – 1,499 g 3 21.4 11 78.6 14 100.0 2 25.0 6 75.0 8 100.0 1.000
Total 5 17.9 23 82.1 28 100.0 3 14.3 18 85.7 21 100.0 > 0.999
Psychomotor
751 – 1,000 g 1 25.0 3 75.0 4 100.0 1 14.3 6 85.7 7 100.0 1.000
1,001 – 1,250 g 2 20.0 8 80.0 10 100.0 1 16.6 5 83.3 6 100.0 1.000
1,251 – 1,499 g 2 14.2 12 85.7 14 100.0 3 37.5 5 62.5 8 100.0 0.309
Total 5 17.9 23 82.1 28 100.0 5 23.8 16 76.2 21 100.0 0.726
Note: Fisher’s exact test.
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procedures to ensure their immediate survival and reduce
later damage. Once critical situations have been overcome,
there is a need for greater long-term hospitalization due to
complications such as infections, necrotizing enterocolitis,
lung problems due to ventilation, periventricular hemor-
rhage, leukomalacia and retinopathy of prematurity. In our
study, we recorded a wide range of complications in both
groups, with patients requiring hospitalization times of
more than 40 days.
We did not identify any precise estimates of the amount of
resources allocated by the Brazilian health care system for the
care of premature newborns. An Italian study13 calculated the
specific hospital costs for the care of very low weight new-
borns, with an average hospitalization time of 59.7 days,
estimating the individual hospital costs at 20,502.00 euros.
Following this proportion, the estimated calculation in our
population would be more than 60,000 Brazilian reais. A
British study14 with the same objectives stratified the costs
by birth weight, obtaining an individual cost per newborn
weighing less than 1,000 g of 26,815.00 pounds, which is
equivalent to 152,845.00 Brazilian reais, and 18,817.00
pounds, which is equivalent to 107,256.00 Brazilian reais, for
those with birth weights between 1,000 and 1,500 g.
In terms of the in-hospital complications detected, the
groups showed similar rates for most of the variables. How-
ever, the CG showed more problems, as their gestational age
at birthwas lower, therewas a higher rate of use of ACs, none
of them received magnesium sulfate, they had poorer con-
ditions in the 5-minute Apgar score, and they had higher
rates of lung dysplasia. These severe complications could be
attributed to the association of two factors: lower gestational
age and lower use of ACs.
It is possible that the clinical characteristics of each group
may explain these differences. The therapeutic labor, mainly
due to the maternal hypertensive state, is often decided on
after an in-depth evaluation and control of the maternal
conditions, enabling a precious gain of several days, includ-
ing the prescription of ACs and magnesium sulfate.
On the other hand, taking into account the causal factors
of premature labor in the CG, the patients are often admitted
in the advanced active phase, which prevents the adoption of
preventative measures to reduce the postnatal risks.
The role of ACs appears to be increasingly decisive in
reducing morbidity and, consequently, costs. An economic
analysis of this issue15 detected that among newborns
weighing < 1,500 g, considering only the survivors, they
were the group that most benefited from ACs, and that
caused a significant reduction in all cost components, and
a reduction of 36% in the total cost was achieved. This issue
also appears to be reflected in the AHG, as ACs were not
administered to 8.2% of the cases, a significant percentage
that is a cause for concern.
In relation to hospital mortality, no significant differences
were detected between the two groups, although the abso-
lute risk of death in the CGwas practically double that of the
AHG. We should emphasize that there is a notable reduction
in mortality rates in both groups when the birth weight
reaches 750 g. These numbersmay be important when facing
critical clinical situations, inwhich bioethical dilemmas need
to be resolved, assisting in the joint decision-making by the
health team and the parents.
Our study did not identify different prognoses depending
on the presence or absence of maternal AH. A Brazilian study
that evaluated factors related to mortality and morbidity in
very low birth weight newborns identified, as relevant risk
factors, a gestational age of less than 30weeks, the use of ACs,
having a cesarean birth, being a male newborn, being an
infant small for gestational age, the presence of respiratory
discomfort syndrome, late sepsis, necrotizing enterocolitis,
and the persistence of ductus arteriosus.16 Based on these
conditions, we can state that newborns in this weight
category have more than 50.0% chance of dying, or surviving
with definitive complications. Our results are close to this
forecast, and do not enable the consideration of the presence
of AH, particularly maternal preeclampsia, as a protective
factor against in-hospital morbidity and mortality.
In relation to the outpatient follow-up of the survivors, a
loss to follow-up of 14 newborns in the AHG (33.3%) and 11
newborns in the CG (34.4%) was reported. Our findings are
higher than the 20.0% of loss to follow-up identified in a
systematic review aimed at estimating risk factors for later
complications and cognitive problems in newborns exposed
to perinatal problems. This is an important aspect to con-
sider, as it illustrates the difficulties in guaranteeing an
effective follow-up for a special population of newborns in
our country.
The evaluations of the ZS regarding the somatic growth in
both groups did not identify any significant differences,
showing a predominant distribution of values considered
adequate for the age groups, although, in the control group, a
higher number of children with scores lower than expected
was identified.
The somatic development of children continues to depend
onprenatal factors, such as the presence ofmaternal diseases
or placental abnormalities and postnatal factors related to
the release of the insulin-like growth hormone, access to
nutrition, and the psychosocial environment. The results of
this study do not enable us to affirm that the different
processes related to prematurity influenced the somatic
development of the children evaluated, even considering
that hypertensive states lead to more placental problems,
requiring fetal circulatory adaptation in the AHG.
On the other hand, the functional complications evaluated
showed high rates in both groups, but without significant
differences between them. One point to consider is the
exclusive use of magnesium sulfate in the AHG, which did
not result in any advantages for this group. Based on a
systematic review published in 2009, we now have consis-
tent evidence to recommend the routine use of magnesium
sulfate in all premature births at between 24 and 34weeks of
gestation, aimed at reducing cerebral palsy in the second
year of life.17,18 It is assumed that the sample size included in
this study did not have sufficient power to identify differ-
ences between the groups.
Loss to follow-up may affect the interpretation of the
results among the survivors. Those with low complications
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or mild limitations may be less willing to attend subsequent
follow-up visits, assuming therewould be no advantage to be
gained from this evaluation, which may have led to an
overestimation of the rate of complications in the newborns
evaluated. On the other hand, children with severe compli-
cations have higher chances of death that would not be
recorded, leading to an underestimation of the cases with
better evolution. It should also be considered that our study
is based in a reference hospital, which receives severe cases
from various regions of the municipality, or even outside the
state of São Paulo, which are limiting factors in terms of
mobility for the newborns and their families.
As final considerations, our study identified significant
rates of morbidity and mortality in both groups of VLBWIs.
The difficulties of postnatal monitoring in both groups are
highlighted, a factor that probably influenced the interpreta-
tion of the results for those who completed all the phases. It
should also be taken into consideration that this first step of
the evaluation does not mean that other problems, such as
school performance and behavioral issues, may not be
detected in future.
Our results refer to the presence of maternal AH, parti-
cularly preeclampsia. It should not be considered a protec-
tive factor in relation to the prognoses of premature newborn
infants, as reported in a classicworkon the subject.19Wealso
observed that our finding is in line with a systematic
review20 that concluded that perinatal factors are less
important than post-natal environmental factors in VLBWIs,
and that follow-up strategies for these children are essential
to reduce future damages.
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